El Gani-Mesrar Myriam, Bonneau Carole, Michenet Patrick, Gourvennec Jean-Baptiste, Tabareau-Delalande Flore
Service de pathologie, centre hospitalier régional d'Orléans, 1, porte Madeleine, 14, avenue de l'Hôpital, 45067 Orléans cedex 2, France.
Service de pathologie, centre hospitalier régional d'Orléans, 1, porte Madeleine, 14, avenue de l'Hôpital, 45067 Orléans cedex 2, France.
Ann Pathol. 2021 Feb;41(1):118-122. doi: 10.1016/j.annpat.2020.06.013. Epub 2020 Jul 6.
Tumors of the perivascular epithelioid cells (PEComa) of the uterus are rare mesenchymal tumors that are characterized by the expression of both melanocyte and smooth muscle markers. It is often difficult to distinguish PEComas from other uterine tumors: endometrial stromal sarcoma, smooth muscle tumors including epithelioid tumors, melanoma and clear cell sarcoma. We report two cases of malignant PEComas of the uterus, treated in two different hospitals, found in women over 60, presenting a clinical picture of metrorrhagia in a context of myomatous uterus. In the first case, the histological examination of the hysterectomy specimen found a diffuse proliferation of epithelioid cells expressing HMB45. In the second case, the question of the differential diagnosis of the PEComa with a uterine epithelioid leiomyosarcoma arose, in front of the weak or even absent expression of the melanocytic immunohistochemical markers (melanA negative and focal HMB 45). The opinion requested from a network of experts (RRePS) had made it possible to validate the diagnosis of PEComa, notably by carrying out a complement of immunohistochemistry (expression of cathepsin K) by the tumor cells. In spite of its rarity, the diagnosis of PEComa should be considered before this type of epithelioid or clear cell uterine tumor because of the possibility of treatment by targeted therapies such as the mTOR (mammalian target of rapamycin) inhibitors.
子宫血管周上皮样细胞肿瘤(PEComa)是一种罕见的间叶组织肿瘤,其特征是同时表达黑素细胞和平滑肌标志物。通常很难将PEComa与其他子宫肿瘤区分开来,如子宫内膜间质肉瘤、包括上皮样肿瘤在内的平滑肌肿瘤、黑色素瘤和透明细胞肉瘤。我们报告了两例子宫恶性PEComa病例,分别在两家不同医院接受治疗,患者均为60岁以上女性,在子宫肌瘤的背景下出现子宫出血的临床表现。第一例中,子宫切除标本的组织学检查发现表达HMB45的上皮样细胞弥漫性增生。第二例中,由于黑素细胞免疫组化标志物(MelanA阴性且HMB45局灶性表达)表达微弱甚至缺失,出现了PEComa与子宫上皮样平滑肌肉瘤鉴别诊断的问题。向专家网络(RRePS)咨询的意见使得PEComa的诊断得以确认,特别是通过肿瘤细胞进行补充免疫组化(组织蛋白酶K的表达)。尽管PEComa罕见,但在诊断此类上皮样或透明细胞子宫肿瘤之前应考虑PEComa的诊断,因为有可能采用靶向治疗,如mTOR(雷帕霉素哺乳动物靶点)抑制剂进行治疗。